v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT05077241 |
Full text link
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
idpa02@hotmail.com |
Registration date
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
2021-10-14 |
Recruitment status
Last imported at : May 11, 2023, 8 a.m. Source : ClinicalTrials.gov |
Recruiting |
Study design
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
Long covid |
Inclusion criteria
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
inclusion criteria: - subjects of both sexes, sedentary, within two months of a diagnosis of covid-19 confirmed by rt-pcr, aged over 18 years and without any underlying respiratory disease, with adequate cognitive status defined through the mini mental state examination and reduced muscle strength respiratory, defined through the assessment of the maximum inspiratory pressure. |
Exclusion criteria
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
- subjects who present any condition that makes it impossible to carry out the assessments and protocols, complications that justify the interruption of data collection, such as syncope, severe chest pain, coughing up blood, those who request withdrawal from the study and who present adverse effects such as hospitalization by exacerbation of the clinical picture. |
Number of arms
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
Universidade Federal do Rio Grande do Norte |
Inclusion age min
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
85 |
Countries
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
Brazil |
Type of patients
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
Patients recovered from covid |
Severity scale
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
N/A |
Total sample size
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
10 |
primary outcome
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
Dyspnea - Medical Research Council;Quality of life (SF-36);Respiratory muscle strength |
Notes
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : Oct. 16, 2021, 3 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "Group with load", "treatment_id": 657, "treatment_name": "Inspiratory muscle training", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "Group without load", "treatment_id": 657, "treatment_name": "Inspiratory muscle training", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}] |